Healthcare Triangle, Inc. Announces 1-for-60 Reverse Stock Split as Part of Nasdaq Compliance Plan
MWN-AI** Summary
Healthcare Triangle, Inc. (Nasdaq: HCTI) has announced a 1-for-60 reverse stock split of its common stock, effective February 10, 2026, at 12:01 a.m. Eastern Time. This corporate action seeks to increase the stock price and assist the company in meeting the Nasdaq Capital Market's minimum bid price requirement of $1.00 per share. Approved by shareholders during a special meeting on February 2, 2026, the reverse split will reduce the total shares outstanding from approximately 45.4 million to around 757,000.
The common stock will continue to trade under the same symbol "HCTI," although it will be assigned a new CUSIP number (42227W 405) following the split. The reverse stock split will be executed without any changes to the par value of $0.00001 per share or the total number of authorized shares. No fractional shares will be distributed; instead, stockholders entitled to fractional shares will have their amounts rounded up at a participant level.
Shareholders recorded as of January 8, 2026, will receive information regarding their new shareholdings following the split from VStock Transfer, LLC, the company’s transfer agent. For additional details, the company directs interested parties to its definitive proxy statement submitted to the U.S. Securities and Exchange Commission on January 20, 2026.
Healthcare Triangle is dedicated to digital transformation solutions in the healthcare sector, focusing on managed services, cloud enablement, and data analytics. Their services cater to hospitals, healthcare organizations, payers, and life sciences, with a commitment to advancing healthcare outcomes and ensuring compliance with stringent data protection standards. For further updates and information, visit their official website.
MWN-AI** Analysis
Healthcare Triangle, Inc. (NASDAQ: HCTI) recently announced a 1-for-60 reverse stock split, a strategic move aimed at regaining compliance with Nasdaq's minimum bid price requirement of $1.00. The reverse split, effective February 10, 2026, will reduce the company's outstanding shares from approximately 45.4 million to about 757,000 shares, which should theoretically elevate the stock price and enhance market perception.
Investors should approach this news with cautious optimism. A reverse stock split can often signal underlying issues, such as low stock price performance, which may lead to skepticism from market participants. Nonetheless, it can also offer a fresh start and improved visibility if the company successfully executes its business strategy post-split.
Healthcare Triangle specializes in digital transformation solutions for the healthcare sector—an industry currently undergoing rapid technological shifts, which presents both opportunities and challenges. Given the company's emphasis on compliance and data protection, highlighted by its HITRUST certification, HCTI is well-positioned in an evolving landscape that increasingly values data security and interoperability.
However, potential investors should scrutinize the company’s performance metrics, such as revenue growth, profit margins, and cash flow, as reverse splits can sometimes mask financial difficulties. It’s also crucial to monitor the broader market conditions and industry trends that could impact Healthcare Triangle's growth trajectory and financial health.
In conclusion, while the reverse stock split could provide a pathway toward regaining compliance and boosting share price, investors should evaluate the fundamental health of the company carefully. Conducting thorough due diligence and keeping a close eye on subsequent performance post-split will be essential in making informed investment decisions.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
PLEASANTON, Calif., Feb. 6, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences industry, today announced that it will effect a 1-for-60 reverse stock split of its common stock. The reverse stock split will become effective at 12:01 a.m. Eastern Time on Tuesday, February 10, 2026, and the Company's common stock will commence trading on the Nasdaq Capital Market on a post-split basis at the opening of the market on February 10, 2026, pending confirmation by the Depository Trust Company and the Nasdaq. The Company's common stock will continue to trade on the Nasdaq Capital Market under the Company's existing trading symbol, "HCTI," and a new CUSIP number 42227W 405 has been assigned as a result of the reverse stock split.
The Company expects that the reverse stock split, which was approved by the Company's stockholders in a special meeting of Stockholders held on February 2, 2026, will increase the price per share of the Company's common stock, and is part of the Company's strategy to regain compliance with the $1.00 minimum bid price requirement of the Nasdaq Capital Market.
At the effective time of the reverse stock split, each sixty (60) shares of the Company's issued and outstanding common stock will be automatically converted into one (1) issued and outstanding share of common stock without any change in the par value of $0.00001 per share or the total number of authorized shares. The reverse stock split will reduce the Company's number of shares outstanding common stock from approximately 45,417,091 shares to approximately 756,952 shares. No fractional shares of common stock will be issued in connection with the reverse stock split, and stockholders who would otherwise be entitled to receive a fractional share will be rounded up at a participant level in lieu thereof.
Stockholders of record as of January 8th, 2026, will be receiving information regarding their share ownership following the reverse stock split from the Company's transfer agent, VStock Transfer, LLC. VStock Transfer can be reached at (212) 828 8436. Additional information about the reverse stock split can be found in the Company's definitive proxy statement on Schedule 14A, filed with the U.S. Securities and Exchange Commission (the "SEC") on January 20, 2026, and available free of charge at the SEC's website sec.gov.
About Healthcare Triangle
Healthcare Triangle, Inc. based in Pleasanton, California, reinforces healthcare progress through breakthrough technology and extensive industry knowledge and expertise. We support healthcare including hospitals and health systems, payers, and pharma/life sciences organizations in their effort to improve health outcomes. Healthcare Triangle achieves HITRUST Certification for Cloud and Data Platform (CaDP), marketed as CloudEz™ and DataEz™. HITRUST Risk-based, 2-year (r2) Certified status demonstrates to our clients the highest standards for data protection and information security. Healthcare Triangle enables the adoption of new technologies, data enlightenment, business agility, and response to immediate business needs and competitive threats. The highly regulated healthcare and life sciences industries rely on Healthcare Triangle for expertise in digital transformation encompassing the cloud, security and compliance, data lifecycle management, healthcare interoperability, and clinical and business performance optimization. For more information, visit www.healthcaretriangle.com.
Forward-Looking Statements and Safe Harbor Notice
All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company's Annual Report filed with the SEC on March 31, 2025, previous filings, subsequent filings and future periodic reports filed with the SEC. All the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.
The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.
Investor Contact
1-800-617-9550
ir@healthcaretriangle.com
SOURCE Healthcare Triangle, Inc.
FAQ**
How does the 1-for-60 reverse stock split announced by Healthcare Triangle Inc. HCTI impact its overall market capitalization and investor perception on the Nasdaq Capital Market?
What specific strategies is Healthcare Triangle Inc. HCTI implementing to regain compliance with the Nasdaq's minimum bid price requirement following the reverse stock split?
Can Healthcare Triangle Inc. HCTI provide more details on the expected benefits of the reverse stock split for shareholders and the company's market presence?
What are the potential risks associated with the reverse stock split for current and prospective investors in Healthcare Triangle Inc. HCTI, especially regarding share liquidity and market performance?
**MWN-AI FAQ is based on asking OpenAI questions about Healthcare Triangle Inc. (NASDAQ: HCTI).
NASDAQ: HCTI
HCTI Trading
-2.64% G/L:
$2.57 Last:
93,695 Volume:
$2.65 Open:
